Medolla, Italy

Eurosets S.r.l.

USPTO Granted Patents = 21

% Expired Patents = 9.5


Trademarks = 10

Forward Citations = 58

Loading Chart...
Loading Chart...

19 inventors (with patents filed for the assignee):

goldMedal Nicola Ghelli (15 out of 29 patents)

silverMedal Paolo Fontanili (12 out of 12 patents)

bronzeMedal Antonio Petralia (9 out of 9 patents)

4.  Edgardo Costa Maianti (9 out of 15 patents)

5.  Roberto Balanzoni (7 out of 7 patents)

6.  Marco Corbelli (3 out of 3 patents)

7.  Fabio Balugani (2 out of 2 patents)

8.  Alessandro Zerbini (2 out of 2 patents)

9.  Edgardo Costa (1 out of 1 patent)

10.  Marius Dinu (1 out of 2 patents)

11.  Ruggero Paratelli (1 out of 1 patent)

12.  Guido Comai (1 out of 1 patent)

13.  Michele Bellancini (1 out of 1 patent)

14.  Mirko Belliato (1 out of 1 patent)

15.  Luca Caleffi (1 out of 1 patent)


21 patents:

Company Overview
Eurosets S.r.l. is a prominent player in the medical device sector, specializing in the development and manufacturing of innovative solutions for critical care and anesthesia. The company focuses on advanced technologies that enhance patient safety and improve clinical outcomes. With a commitment to quality and innovation, Eurosets serves healthcare providers globally, offering a range of products designed to meet the evolving needs of medical professionals in various settings.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

21 Patents

#1 in Medolla

#435 in Italy

#30,001 in the World

Medolla, IT
Medolla, Italy
Forward Citations = 58

19 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eurosets S.r.l.. Retrieved from https://idiyas.com/company/eurosets-s-r-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…